SCHEMBL7920726

SCHEMBL7920726

Cc1c(N(C)C)ccc(Br)c1N=C1N=CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154433 0.76 MAPT (0.31)
SCHEMBL11248683 0.75 PARP10 (0.31)
Hydrochloric Acid SCHEMBL11004810 0.65 GAA (0.32)
Hydrochloric Acid SCHEMBL7609599 0.62 DYRK3 (0.34)
SCHEMBL5151390 0.61
SCHEMBL8762100 0.61 MAPT (0.33)
SCHEMBL11591230 0.60 MEN1 (0.35)
SCHEMBL6787325 0.58 CHEK1 (0.36)
SCHEMBL11068818 0.58 KIF11 (0.30)
SCHEMBL11362454 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6268389-B1 Treatment of urinary incontinence by administration of α1L-adrenoceptor agonists BOEHRINGER INGELHEIM KG (DE) 2001-07-31 US disclosed